Thamer A. Alsubia,
Mohamed W. Attwaab,
Ahmed H. Bakheita,
Hany W. Darwish*ac,
Hatem A. Abuelizza and
Adnan A. Kadia
aDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P. O. Box 2457, Riyadh, 11451, Saudi Arabia. E-mail: hdarwish@ksu.edu.sa; Fax: +966 1146 76 220; Tel: +966 1146 70237
bStudents’ University Hospital, Mansoura University, Mansoura 35516, Egypt
cAnalytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt
First published on 23rd June 2020
Correction for ‘In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling’ by Thamer A. Alsubi et al., RSC Adv., 2020, 10, 22668–22683, DOI: 10.1039/D0RA01624A.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2020 |